Search
Search Results
-
Lipoprotein(a): what clinicians need to know
204PDF: 488HTML: 23 -
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
770PDF: 2229Supplementary: 300Appendix: 247 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
721PDF: 182Supplementary: 137Appendix: 108HTML: 18 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
114PDF: 197Supplementary: 142HTML: 16 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
728PDF: 175Supplementary: 144Appendix: 104HTML: 18 -
Applicability of obesity clinical practice guidelines in low- and middle-income countries
962PDF: 506Appendix: 135HTML: 9 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1048pdf: 230Supplementary Material: 38HTML: 99 -
Epidemiology of peripartum cardiomyopathy in Africa
2169PDF: 484HTML: 73 -
-
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3276PDF: 494Appendix: 374HTML: 23 -
Modulation of cardiac metabolism in heart failure
2307PDF: 1126HTML: 16 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1855PDF: 496SUPPLEMENTARY MATERIAL: 293GRAPHICAL ABSTRACT: 260HTML: 8 -
-
Safety and efficacy of left atrial appendage closure in cancer versus non-cancer patients: a systematic review and meta-analysis
1080PDF: 246Supplementary: 153HTML: 77 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2216PDF: 381Appendix B: 427Appendix A: 317HTML: 2 -

